SEC Filings

ENVISION HEALTHCARE CORP filed this Form 8-K/A on 08/04/2017
Entire Document

Washington, D.C. 20549

(Amendment No. 1)


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 25, 2017

(Exact Name of Registrant as Specified in its Charter)

(State or Other Jurisdiction of Incorporation)
 File Number)
(I.R.S. Employer
 Identification No.)
1A Burton Hills Boulevard
Nashville, Tennessee
(Address of Principal
Executive Offices)
(Zip Code)

(615) 665-1283
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Explanatory Note

This Amendment No. 1 on Form 8-K/A (the “Amendment”) amends the Current Report on Form 8-K of Envision Healthcare Corporation (the “Company”) filed on May 25, 2017 (the “Original Form 8-K”). The Original Form 8-K reported the final voting results of the Company’s 2017 Annual Meeting of Stockholders held on May 25, 2017 (the “2017 Annual Meeting”). The purpose of this Amendment is to disclose the Company’s decision regarding how frequently it will conduct future stockholder advisory votes to approve the compensation of the Company’s named executive officers (“Say-on-Pay”). This Amendment does not amend or modify the Original 8-K in any other respect.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As previously reported in the Original Form 8-K, at the 2017 Annual Meeting the Company’s stockholders approved, on an advisory basis, holding future Say-on-Pay votes every year. On August 1, 2017, the Company’s Board of Directors (the “Board”) determined that the Company will hold an advisory Say-on-Pay vote annually. The Company’s Board will re-evaluate this determination following its next stockholder advisory vote on the frequency of Say-on-Pay votes, which is required to occur no later than the Company's 2023 Annual Meeting of Stockholders.


Pursuant to the requirements of the Securities Exchange Act of 1934, Envision Healthcare Corporation has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Envision Healthcare Corporation
/s/ Claire M. Gulmi
Claire M. Gulmi
Executive Vice President and Chief Financial Officer
(Principal Financial and Duly Authorized Officer)

Date:    August 4, 2017